D H Sherman
Overview
Explore the profile of D H Sherman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
1099
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hagan A, Tripathi A, Berger D, Sherman D, Hanna P
mBio
. 2017 Oct;
8(5).
PMID: 29042503
No abstract available.
2.
Hagan A, Tripathi A, Berger D, Sherman D, Hanna P
mBio
. 2017 Sep;
8(5).
PMID: 28900020
-a Gram-positive, spore-forming bacterium-causes anthrax, a highly lethal disease with high bacteremia titers. Such rapid growth requires ample access to nutrients, including iron. However, access to this critical metal is...
3.
Williams M, Rahn J, Smith S, Joshi A, Sherman D
Appl Environ Microbiol
. 2005 Dec;
64(1):383.
PMID: 16349493
[This corrects the article on p. 2540 in vol. 62, PMID: 8779593.].
4.
Kyung Y, Sherman D, Hu W
Biotechnol Prog
. 2001 Dec;
17(6):1000-7.
PMID: 11735432
Linkage between structural and regulatory genes implies that a direct correlation should exist between the spatio-temporal distribution of their expression. Green fluorescent protein (GFP) and cyan fluorescent protein (CFP) were...
5.
Zhang Q, Sherman D
J Nat Prod
. 2001 Nov;
64(11):1447-50.
PMID: 11720530
Novamethymycin (9), a novel macrolide antibiotic, was isolated from Streptomyces venezuelae, the producer of methymycin (4) and neomethymycin (5). Spectroscopic analysis of 9 indicated that it is highly related to...
6.
Baumann R, Hodnick W, Seow H, Belcourt M, Rockwell S, Sherman D, et al.
Cancer Res
. 2001 Nov;
61(21):7770-6.
PMID: 11691791
The clinical utility of antineoplastic agents is limited by the development of drug resistance by tumors. Mitomycin C (MC) is a bacterial product that must be enzymatically reduced to exert...
7.
Penketh P, Hodnick W, Belcourt M, Shyam K, Sherman D, Sartorelli A
J Biol Chem
. 2001 Jul;
276(37):34445-52.
PMID: 11457837
Mitomycin C requires reductive activation to cross-link DNA and express anticancer activity. Reduction of mitomycin C (40 microm) by sodium borohydride (200 microm) in 20 mm Tris-HCl, 1 mm EDTA...
8.
Varoglu M, Mao Y, Sherman D
J Am Chem Soc
. 2001 Jul;
123(27):6712-3.
PMID: 11439066
No abstract available.
9.
Kyung Y, Hu W, Sherman D
Mol Microbiol
. 2001 May;
40(3):530-41.
PMID: 11359561
The DNA-binding capability of a key secondary metabolite regulatory element (CcaR) in the Streptomyces clavuligerus cephamycin C pathway was investigated by gel mobility retardation and DNase I footprinting analysis. These...
10.
Wilson D, Xue Y, Reynolds K, Sherman D
J Bacteriol
. 2001 May;
183(11):3468-75.
PMID: 11344155
The Streptomyces venezuelae pikD gene from the pikromycin biosynthetic cluster was analyzed, and its deduced product (PikD) was found to have amino acid sequence homology with a small family of...